EP Patent

EP3300727A1 — Glycogen or polysaccharide storage disease treatment method

Assigned to Baylor Research Institute · Expires 2018-04-04 · 8y expired

What this patent protects

A method for treating glycogen storage disease by administering an effective amount of a composition that includes ketogenic odd carbon fatty acids that ameliorate the symptoms of these diseases.

USPTO Abstract

A method for treating glycogen storage disease by administering an effective amount of a composition that includes ketogenic odd carbon fatty acids that ameliorate the symptoms of these diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP3300727A1
Jurisdiction
EP
Classification
—
Expires
2018-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Baylor Research Institute
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.